PURPOSE: Injection snoreplasty is introduced as an innovative, safe, and effective palatal rigidity procedure with minimal cost and discomfort for controlling simple snoring. A well described sclerosing agent, ethanolamine oleate 5%, is injected into the soft palate for reduction and/or elimination palatal flutter snoring.
METHODS: Thirty four patients with a diagnosis of simple palatal flutter snoring (apnea/hypopnea index less than 5/h) were enrolled in this study. Office treatment sessions were performed 6 weeks apart. Success was judged by subjective improvement in snoring and evidence of palatal scarring.
RESULTS: Thirty two patients reported significant decrease in snoring. There were no significant postinjection complications. Visual analog pain scale confirmed minimal discomfort. Most patients received more than one injection (average 1.8) in order to induce optimal palatal stiffening.
CONCLUSION: Injection snoreplasty is a simple, safe, and effective office treatment for simple snoring. Advantages over current snoring procedures include simplicity,low cost, decrease posttreatment pain levels, and minimal or no convalescence.
CLINICAL IMPLICATIONS: Injection snoreplasty is a simple, safe, low cst and effective office treatment for simple snoring.
DISCLOSURE: Abdelbaset Saleh, No Financial Disclosure Information; No Product/Research Disclosure Information